Stay updated with breaking news from Recurrent Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An unusual cause of ischemic stroke -- the presence of structural bone and cartilage anomalies which cause mechanical stress to arteries supplying the brain -- is highlighted in a new study.
The drug, butylphthalide, was associated with better outcomes after ischemic stroke after thrombolysis or endovascular therapy.
A combination of two drugs showed promising phase 2 results, including a reduction in cognitive impairment in patients with lacunar stroke, and may be a potential new approach to small vessel disease.
These results suggest that continuous monitoring to detect AF should be considered in a larger population of stroke patients rather than just those with cryptogenic stroke, the investigators say.
STROKE-AF’s extended follow-up suggests short-term monitoring isn’t enough, but the significance of any AF found is unknown.